{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:26:57Z","timestamp":1787164017510,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.pntd.0014608","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000}}],"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172441"],"award-info":[{"award-number":["82172441"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Funding for Jiangsu Province Science and Technology Plan (Key Research and Development Program for Social Development)","award":["BE2023738"],"award-info":[{"award-number":["BE2023738"]}]},{"name":"Key Laboratory Project in Suzhou City","award":["SZS2024018"],"award-info":[{"award-number":["SZS2024018"]}]},{"name":"Suzhou City\u2019s Project for Strengthening Science and Education and Promoting Healthcare","award":["QNXM2024076"],"award-info":[{"award-number":["QNXM2024076"]}]},{"name":"Kunshan City\u2019s Municipal Science and Technology Special Project","award":["KS2510"],"award-info":[{"award-number":["KS2510"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Although prior research in China has linked previous schistosome infection (PSI) to lower risks of metabolic syndrome and cardiorenovascular conditions, the association between PSI and hyperuricemia, a recognized risk factor for these conditions, remains unclear. This study examines the relationship between PSI and hyperuricemia and identifies factors associated with hyperuricemia incidence in individuals with PSI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective cohort study included 23,051 adults from eight health centers in Kunshan (2018\u20132021). Exposure was defined by self-reported PSI, validated by liver B-ultrasound. The primary outcome was hyperuricemia. Baseline and follow-up data encompassed height, weight, blood pressure, serum uric acid, glucose, renal function parameters, liver function, and lipid profiles. Cox proportional hazard models were employed to analyze the relationship between PSI and hyperuricemia, adjusting for demographic, lifestyle, and clinical variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 23,051 participants included in this study, 4,677 (20.29%) had a history of schistosome infection, and 87.53% of those with PSI were over the age of 64. During 60,335 person-years of follow-up, 4,417 incident cases of hyperuricemia were recorded. The incidence rate was 64.91 per 1,000 person-years in the PSI group and 75.38 per 1,000 person-years in the non-PSI group. The overall cumulative hazard differed significantly among individuals, with the incidence of hyperuricemia being 17.36% (95% CI: 16.28\u201318.48%) and 19.62% (95% CI: 19.05\u201320.20%) in PSI and Non-PSI groups. After adjusting for confounders, PSI was associated with an 11% lower risk of hyperuricemia (HR: 0.89, 95% CI: 0.82\u20130.97,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this prospective cohort study, PSI was observed to be associated with a lower risk of incident hyperuricemia. This finding reflects an observational association and does not establish causality. From a public health standpoint, schistosome infection remains a serious disease requiring continued prevention and control. Further investigations are needed to clarify the underlying mechanisms linking PSI to hyperuricemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0014608","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T17:35:53Z","timestamp":1786383353000},"page":"e0014608","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Previous schistosome infection and the risk of incident hyperuricemia: A prospective cohort study"],"prefix":"10.1371","volume":"20","author":[{"given":"Congyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0029-7874","authenticated-orcid":true,"given":"Ke","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"10","key":"pntd.0014608.ref001","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","article-title":"Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels","volume":"51","author":"A Tin","year":"2019","journal-title":"Nat Genet"},{"issue":"7","key":"pntd.0014608.ref002","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"M Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"pntd.0014608.ref003","article-title":"Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies","author":"X Li","year":"2017","journal-title":"BMJ"},{"key":"pntd.0014608.ref004","first-page":"762820","article-title":"Prevalence of hyperuricemia and Gout in Mainland China from 2000 to 2014: a systematic review and meta-Analysis","volume":"2015","author":"R Liu","year":"2015","journal-title":"Biomed Res Int"},{"issue":"10","key":"pntd.0014608.ref005","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Y Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"pntd.0014608.ref006","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1291\/hypres.27.227","article-title":"Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan","volume":"27","author":"K Nagahama","year":"2004","journal-title":"Hypertens Res"},{"issue":"2","key":"pntd.0014608.ref007","doi-asserted-by":"crossref","DOI":"10.1186\/ar3322","article-title":"Hyperuricemia and the risk for subclinical coronary atherosclerosis--data from a prospective observational cohort study","volume":"13","author":"E Krishnan","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"pntd.0014608.ref008","doi-asserted-by":"crossref","DOI":"10.1186\/ar3684","article-title":"Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction","volume":"14","author":"E Krishnan","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"pntd.0014608.ref009","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.amjmed.2005.03.043","article-title":"Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?","volume":"118","author":"JF Baker","year":"2005","journal-title":"Am J Med"},{"issue":"9936","key":"pntd.0014608.ref010","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"DG Colley","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"pntd.0014608.ref011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"DP McManus","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"pntd.0014608.ref012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk","volume":"6","author":"P Steinmann","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"pntd.0014608.ref013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2049-9957-3-21","article-title":"Global burden, distribution, and interventions for infectious diseases of poverty","volume":"3","author":"ZA Bhutta","year":"2014","journal-title":"Infect Dis Poverty"},{"issue":"13","key":"pntd.0014608.ref014","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1017\/S0031182009991272","article-title":"Control of schistosomiasis in sub-Saharan Africa: progress made, new opportunities and remaining challenges","volume":"136","author":"JR Stothard","year":"2009","journal-title":"Parasitology"},{"issue":"8","key":"pntd.0014608.ref015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1473-3099(15)00066-3","article-title":"Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis","volume":"15","author":"Y-S Lai","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pntd.0014608.ref016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2049-9957-2-2","article-title":"Epidemiology and interactions of Human Immunodeficiency Virus - 1 and Schistosoma mansoni in sub-Saharan Africa","volume":"2","author":"HD Mazigo","year":"2013","journal-title":"Infect Dis Poverty"},{"key":"pntd.0014608.ref017","first-page":"39","article-title":"Epidemiological Features and Effectiveness of Schistosomiasis Control Programme in Lake and Marshland Region in The People\u2019s Republic of China.","volume-title":"Advances in Parasitology","author":"SQ Zhang","year":"2016"},{"key":"pntd.0014608.ref018","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.actatropica.2014.12.004","article-title":"Schistosomiasis transmission and control in China","volume":"143","author":"L Zou","year":"2015","journal-title":"Acta Trop"},{"issue":"5","key":"pntd.0014608.ref019","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/eji.200323910","article-title":"Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes","volume":"33","author":"P Zaccone","year":"2003","journal-title":"Eur J Immunol"},{"issue":"3","key":"pntd.0014608.ref020","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4049\/jimmunol.166.3.1903","article-title":"IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis","volume":"166","author":"AC La Flamme","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"pntd.0014608.ref021","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1172\/JCI64617","article-title":"Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs","volume":"123","author":"M Subramanian","year":"2013","journal-title":"J Clin Invest"},{"issue":"2","key":"pntd.0014608.ref022","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-2517","article-title":"Association of previous schistosome infection with diabetes and metabolic syndrome: a cross-sectional study in rural China","volume":"98","author":"Y Chen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"pntd.0014608.ref023","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijpara.2015.01.001","article-title":"Potential long-term effects of previous schistosome infection may reduce the atherogenic index of plasma in Chinese men","volume":"45","author":"S-W Shen","year":"2015","journal-title":"Int J Parasitol"},{"issue":"7","key":"pntd.0014608.ref024","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/pim.12187","article-title":"The potential long-term effect of previous schistosome infection reduces the risk of metabolic syndrome among Chinese men","volume":"37","author":"S-W Shen","year":"2015","journal-title":"Parasite Immunol"},{"issue":"2","key":"pntd.0014608.ref025","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ijcard.2014.08.128","article-title":"The potential long-term effect of previous schistosome infection may reduce the risk factors for cardiovascular diseases","volume":"177","author":"S-W Shen","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"pntd.0014608.ref026","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12877-023-04203-7","article-title":"Association of mitochondrial DNA copy number with chronic kidney disease in older adults","volume":"23","author":"Y Liu","year":"2023","journal-title":"BMC Geriatr"},{"issue":"5","key":"pntd.0014608.ref027","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/cpt.3028","article-title":"CYP2C19 loss-of-function variants associated with long-term ischemic stroke events during Clopidogrel treatment in the Chinese population","volume":"114","author":"P Wu","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"pntd.0014608.ref028","doi-asserted-by":"crossref","first-page":"5125884","DOI":"10.1155\/2022\/5125884","article-title":"Impact of visit-to-visit triglyceride-glucose index variability on the risk of cardiovascular disease in the elderly","volume":"2022","author":"F Chen","year":"2022","journal-title":"Int J Endocrinol"},{"issue":"1","key":"pntd.0014608.ref029","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1038\/s41598-017-05751-w","article-title":"Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population","volume":"7","author":"J Wu","year":"2017","journal-title":"Sci Rep"},{"issue":"7564","key":"pntd.0014608.ref030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/bmj.333.7564.362","article-title":"Overweight and obesity in China","volume":"333","author":"Y Wu","year":"2006","journal-title":"BMJ"},{"issue":"1","key":"pntd.0014608.ref031","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12967-016-0866-0","article-title":"Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study","volume":"14","author":"F Wei","year":"2016","journal-title":"J Transl Med"},{"issue":"2","key":"pntd.0014608.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212702","article-title":"Association between previous schistosome infection and incident hyperuricemia: a prospective cohort study in China","volume":"14","author":"G Wang","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"pntd.0014608.ref033","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/1521-4141(200002)30:2<470::AID-IMMU470>3.0.CO;2-T","article-title":"Elevated type 1, diminished type 2 cytokines and impaired antibody response are associated with hepatotoxicity and mortalities during Schistosoma mansoni infection of CD4-depleted mice","volume":"30","author":"PG Fallon","year":"2000","journal-title":"Eur J Immunol"},{"issue":"5","key":"pntd.0014608.ref034","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.immuni.2018.10.016","article-title":"Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules","volume":"49","author":"RM Maizels","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"pntd.0014608.ref035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/eji.201242794","article-title":"ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection","volume":"43","author":"SA Redpath","year":"2013","journal-title":"Eur J Immunol"},{"issue":"4","key":"pntd.0014608.ref036","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1172\/JCI36534","article-title":"Th2 cell hyporesponsiveness during chronic murine schistosomiasis is cell intrinsic and linked to GRAIL expression","volume":"119","author":"JJ Taylor","year":"2009","journal-title":"J Clin Invest"},{"issue":"4","key":"pntd.0014608.ref037","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jaci.2007.06.009","article-title":"Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection","volume":"120","author":"HH Smits","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"pntd.0014608.ref038","doi-asserted-by":"crossref","first-page":"1229665","DOI":"10.3389\/fimmu.2023.1229665","article-title":"Corrigendum: Dynamics of host immune response development during Schistosoma mansoni infection","volume":"14","author":"AH Costain","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"pntd.0014608.ref039","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress\u2014relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"ME Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pntd.0014608.ref040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00406-017-0817-7","article-title":"Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression","volume":"268","author":"F Bartoli","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"9","key":"pntd.0014608.ref041","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.3390\/nu12092600","article-title":"Association between serum uric acid levels, nutritional and antioxidant status in patients on hemodialysis","volume":"12","author":"E Dom\u00ednguez-Zambrano","year":"2020","journal-title":"Nutrients"},{"key":"pntd.0014608.ref042","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2147\/JIR.S357159","article-title":"Combination of uric acid and pro-inflammatory cytokines in discriminating patients with gout from healthy controls","volume":"15","author":"X Zha","year":"2022","journal-title":"J Inflamm Res"},{"issue":"3","key":"pntd.0014608.ref043","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/08820139.2013.864667","article-title":"Pro-inflammatory effects of uric acid in the gastrointestinal tract","volume":"43","author":"JK Crane","year":"2014","journal-title":"Immunol Invest"},{"issue":"6","key":"pntd.0014608.ref044","article-title":"Uric acid and inflammation in kidney disease","volume":"318","author":"SW Jung","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"pntd.0014608.ref045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11906-006-0007-x","article-title":"Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system","volume":"8","author":"X Zhou","year":"2006","journal-title":"Curr Hypertens Rep"},{"key":"pntd.0014608.ref046","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.niox.2013.04.003","article-title":"Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: a mechanism for uric acid-induced cardiovascular disease development","volume":"32","author":"J-H Park","year":"2013","journal-title":"Nitric Oxide"},{"issue":"4","key":"pntd.0014608.ref047","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism","volume":"64","author":"X Wan","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"pntd.0014608.ref048","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"L Du","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"pntd.0014608.ref049","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","article-title":"An update on the genetic architecture of hyperuricemia and gout","volume":"17","author":"TR Merriman","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"pntd.0014608.ref050","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/acr.23926","article-title":"Coexistent hyperuricemia and gout in rheumatoid arthritis: associations with comorbidities, disease activity, and mortality","volume":"72","author":"A Chiou","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"pntd.0014608.ref051","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.3390\/nu13124504","article-title":"Dietary inflammatory index and the risk of hyperuricemia: a cross-sectional study in chinese adult residents","volume":"13","author":"C Ye","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"pntd.0014608.ref052","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1590\/S0102-311X2011000200018","article-title":"Hyperuricemia and associated factors: a cross-sectional study of Japanese-Brazilians","volume":"27","author":"J Poletto","year":"2011","journal-title":"Cad Saude Publica"},{"issue":"8","key":"pntd.0014608.ref053","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3390\/jcm8081202","article-title":"Is hyperuricemia, an early-onset metabolic disorder, causally associated with cardiovascular disease events in Han Chinese?","volume":"8","author":"KM Chiang","year":"2019","journal-title":"J Clin Med"},{"key":"pntd.0014608.ref054","first-page":"7545137","article-title":"Gender- and age-specific differences in the association of hyperuricemia and hypertension: a cross-sectional study","volume":"2019","author":"X Lin","year":"2019","journal-title":"Int J Endocrinol"},{"key":"pntd.0014608.ref055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12944-019-1077-5","article-title":"Age-related and gender-stratified differences in the association between high triglyceride and risk of hyperuricemia","volume":"18","author":"L Zhang","year":"2019","journal-title":"Lipids Health Dis"},{"issue":"1","key":"pntd.0014608.ref056","doi-asserted-by":"crossref","first-page":"15683","DOI":"10.1038\/s41598-020-72780-3","article-title":"Prevalence and associated factors of hyperuricemia among urban adults aged 35-79 years in southwestern China: a community-based cross-sectional study","volume":"10","author":"XB Huang","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"pntd.0014608.ref057","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/ijerph13070732","article-title":"The relation of moderate alcohol consumption to hyperuricemia in a rural general population","volume":"13","author":"Z Li","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"pntd.0014608.ref058","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12967-020-02590-8","article-title":"Association of hypertension and hypertriglyceridemia on incident hyperuricemia: an 8-year prospective cohort study","volume":"18","author":"Y Zhang","year":"2020","journal-title":"J Transl Med"},{"issue":"1","key":"pntd.0014608.ref059","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12944-021-01556-z","article-title":"The association of lipid ratios with hyperuricemia in a rural Chinese hypertensive population","volume":"20","author":"Y Yu","year":"2021","journal-title":"Lipids Health Dis"},{"key":"pntd.0014608.ref060","doi-asserted-by":"crossref","first-page":"773220","DOI":"10.3389\/fnut.2022.773220","article-title":"The association between hyperuricemia and obesity metabolic phenotypes in Chinese general population: a retrospective analysis","volume":"9","author":"X Feng","year":"2022","journal-title":"Front Nutr"},{"key":"pntd.0014608.ref061","doi-asserted-by":"crossref","first-page":"573452","DOI":"10.3389\/fendo.2020.573452","article-title":"Sex-specific differences in the association of metabolically healthy obesity with hyperuricemia and a network perspective in analyzing factors related to hyperuricemia","volume":"11","author":"S Tian","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"pntd.0014608.ref062","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12902-023-01528-7","article-title":"Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China","volume":"24","author":"Y Fang","year":"2024","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"pntd.0014608.ref063","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12944-020-1197-y","article-title":"The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study","volume":"19","author":"J Liang","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"10287","key":"pntd.0014608.ref064","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"N Dalbeth","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"pntd.0014608.ref065","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2023.01.004","article-title":"Genetic risk, adherence to a healthy lifestyle, and hyperuricemia: the TCLSIH cohort study","volume":"136","author":"T Zhang","year":"2023","journal-title":"Am J Med"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0014608","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:45:45Z","timestamp":1787161545000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014608"}},"subtitle":[],"editor":[{"given":"David J.","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0014608","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}